Inflammatory Bowel Disease Patients’ Acceptance for Switching from Intravenous Infliximab or Vedolizumab to Subcutaneous Formulation: The Nancy Experience

por Remy, Clotilde, Caron, Bénédicte, Gouynou, Celia, Haghnejad, Vincent, Jeanbert, Elodie, Netter, Patrick, Danese, Silvio, Peyrin-Biroulet, Laurent
Publicado 2022

Esophageal Motility Disorders Associated With Death or Allograft Dysfunction After Lung Transplantation? Results of a Retrospective Monocentric Study

por Gouynou, Célia, Philit, François, Mion, François, Tronc, François, Sénéchal, Agathe, Giai, Joris, Rabain, Anne-Marie, Mornex, Jean-François, Roman, Sabine
Publicado 2020